Get started
Author

Arunabh Choudhury

Observed institution: Jamia Millia Islamia
ORCID: 0000-0002-7217-1744
Observed ORCID: 0000-0002-7217-1744
OpenAlex ID: A5059428347
Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach
2021 · Taj Mohammad, Arunabh Choudhury, et al. · Frontiers in Cellular and Infection Microbiology · 61
PDF
Structural genomics approach to investigate deleterious impact of nsSNPs in conserved telomere maintenance component 1
2021 · Arunabh Choudhury, Taj Mohammad, et al. · Scientific Reports · 34
PDF
Comparative analysis of web-based programs for single amino acid substitutions in proteins
2022 · Arunabh Choudhury, Taj Mohammad, et al. · PLoS ONE · 28
PDF
Understanding of Alzheimer's disease pathophysiology for therapeutic implications of natural products as neuroprotective agents
2025 · Sneh Prabha, Arunabh Choudhury, et al. · Ageing Research Reviews · 26
Exploring MTH1 inhibitory potential of Thymoquinone and Baicalin for therapeutic targeting of breast cancer
2024 · Aaliya Taiyab, Arunabh Choudhury, et al. · Biomedicine & Pharmacotherapy · 20
Marine polysaccharides for antibiofilm application: A focus on biomedical fields
2024 · Geum-Jae Jeong, Fazlurrahman Khan, et al. · International Journal of Biological Macromolecules · 18
Impact of Deleterious Mutations on Structure, Function and Stability of Serum/Glucocorticoid Regulated Kinase 1: A Gene to Diseases Correlation
2021 · Mohamed F. AlAjmi, Shama Khan, et al. · Frontiers in Molecular Biosciences · 18
PDF
Identification of natural product-based effective inhibitors of spleen tyrosine kinase (SYK) through virtual screening and molecular dynamics simulation approaches
2023 · Tufail Ali, Farah Anjum, et al. · Journal of Biomolecular Structure and Dynamics · 17
Probing Baicalin as potential inhibitor of Aurora kinase B: A step towards lung cancer therapy
2023 · Saba Noor, Arunabh Choudhury, et al. · International Journal of Biological Macromolecules · 16
Harnessing memantine in Alzheimer's disease therapy through inhibition of microtubule affinity-regulating kinase: Mechanistic insights
2024 · Saleha Anwar, Arunabh Choudhury, et al. · International Journal of Biological Macromolecules · 11
Structure-guided discovery of tau-phosphorylating kinase DYRK1A inhibitors for therapeutic targeting of neuroinflammatory diseases: Insights from microsecond MD simulation and MMPBSA analyses
2025 · Arunabh Choudhury, Sumaiya Khan, et al. · Biochemical and Biophysical Research Communications · 10
Apigenin-mediated MARK4 inhibition: a novel approach in advancing Alzheimer’s disease therapeutics
2025 · Afzal Hussain, Deeba Shamim Jairajpuri, et al. · Molecular Diversity · 10
Current advancement in AI-integrated drug discovery: Methods and applications
2025 · Yash Mathur, Arunabh Choudhury, et al. · Biotechnology Advances · 8
Multi-targeted approach via apigenin-7-O-glucoside for therapeutic intervention of Tau phosphorylating kinases in Alzheimer’s disease
2025 · Sneh Prabha, Arunabh Choudhury, et al. · 3 Biotech · 8
PDF
Discovering potential therapeutic targets in glioblastoma multiforme using a multi-omics approach
2025 · Mohammad Umar Saeed, Arunabh Choudhury, et al. · Pathology - Research and Practice · 8
Structure-guided screening identified bioactive phytoconstituents Hernandonine and Anolobine as potential inhibitors of dual specificity protein kinase CLK1
2025 · Sumaiya Khan, Arunabh Choudhury, et al. · Scientific Reports · 7
PDF
Targeting tau hyperphosphorylation-mediated neuroinflammation in Alzheimer's disease via ABL1 kinase inhibition: Insights from microsecond MD simulation and MM/PBSA analyses
2025 · Arunabh Choudhury, Sneh Prabha, et al. · International Journal of Biological Macromolecules · 6
Identification of potential inhibitors of Fyn-Kinase from bioactive phytochemicals of Berberis lycium for therapeutic targeting of neurodegenerative disease
2025 · Sneh Prabha, Arunabh Choudhury, et al. · Journal of Biomolecular Structure and Dynamics · 6
Discovering novel inhibitors of RfaH from Klebsiella pneumoniae to combat antimicrobial resistance
2024 · Mohammad Umar Saeed, Shazia Ahmed, et al. · Archives of Microbiology · 6
Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B
2024 · Saba Noor, Arunabh Choudhury, et al. · Molecular and Cellular Biochemistry · 6
PDF
Validation of drug targets using molecular methodologies and enzymatic activity assays for validation of inhibitory potential
2024 · Sumaiya Khan, Saleha Anwar, et al. · Elsevier eBooks · 5
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease
2025 · Mohammad Taufeeq, Arunabh Choudhury, et al. · Journal of Alzheimer s Disease · 3
Synergistic effect of the rifaximin–berberine combination against Klebsiella pneumoniae: RfaH targeting supported by MD simulation
2026 · Anam Ashraf, Mohammad Ali Khan, et al. · Biomolecules and Biomedicine · 2
PDF
Repurposing resveratrol for redox-mediated inhibition of MTH1 in breast cancer
2025 · Aaliya Taiyab, Arunabh Choudhury, et al. · Scientific Reports · 2
PDF
Identification of potential inhibitors of interleukin-2-inducible T-cell kinase: insights from docking, molecular dynamics, MMPBSA and free energy landscape studies
2025 · Shazia Ahmed, Arunabh Choudhury, et al. · Amino Acids · 2
PDF
Works count: 38
Citation count: 345
H-index: 10
I10-index: 12
Year
Topic
Type